The Future of Psychedelics: Insights from Rick Doblin

In this conversation, Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), shares his vision for the future of psychedelics, highlighting their potential to treat mental health issues like PTSD. He discusses the successful phase three clinical trials of MDMA-assisted therapy, its implications for psychiatry, and the long journey toward legalization and acceptance of psychedelics in society. Doblin emphasizes the importance of context in using psychedelics safely and effectively, and how personal responsibility and social consciousness are key components of their integration into therapeutic practices